Mostrar el registro sencillo del ítem

dc.contributor.author
Mirakian, Nadia Talín  
dc.contributor.author
Papademetrio, Daniela Laura  
dc.contributor.author
Sülsen, Valeria Patricia  
dc.contributor.author
Carlucci, Adriana Mónica  
dc.date.available
2025-05-30T13:59:56Z  
dc.date.issued
2024  
dc.identifier.citation
Mirakian, Nadia Talín; Papademetrio, Daniela Laura; Sülsen, Valeria Patricia; Carlucci, Adriana Mónica; Synthetic and Natural Drug Nanodelivery Systems Used in Oncology Treatment; Springer; 2024; 1-33  
dc.identifier.isbn
9783031324581  
dc.identifier.uri
http://hdl.handle.net/11336/263066  
dc.description.abstract
Cancer is considered the principal cause of death worldwide, with breast andlung cancer the most prevalent type in women and men, respectively. Cancertreatments, such as chemotherapy and radiotherapy, have disadvantages due tolack of selectivity toward tumor cells and inefficient drug delivery to tumor sites.Nanotechnology presents promising solutions to these limitations. In this sense,the use of nanocarriers can enhance the precision and efficacy of the treatmentthrough innovative nano-based interventions.Nanoparticles have a wide application in medical contexts due to their size inwhich quantum phenomena take place. Therefore, they presented a high surfaceto-mass ratio along with the ability to transport diverse compounds. They havethe capacity to improve therapeutic efficacy and mitigate adverse effects throughthe enhancement of drug stability, reduction of adverse reactions, and modulationof pharmacokinetic profiles. Nanomedicine is emerging as a gateway for diagnosticand treatment strategies that overcome many obstacles faced by conventionaltherapies.Plant-based herbal medicines, natural compounds, and their derivatives areconsidered promising in cancer research and treatment. Several phytochemicalgroups such as polyphenols and their derivatives, naphtoquinones, and sesquiterpenelactones are under preclinical and clinical investigations in innovative drugdelivery systems with the objective to enhance pharmacological parameters,such as bioavailability, efficacy, and safety. The elucidation of cancer biologyhas spurred advancements in nanoparticle-based drug delivery, offering potentialbenefits such as reduced toxicity, circumvention of multidrug resistance, andimproved drug solubility. Consequently, the integration of immunotherapy withnanoparticles has emerged as a viable strategy to prevent tumor recurrence andmetastasis. Concurrently, clinical trials are exploring combinations of conventionaltherapies with other modalities—immunotherapy, photothermal ablation,and gene therapy—as potential treatments for various tumors.This chapter provides a comprehensive analysis of preclinical and clinicalinvestigations related to compounds of both natural and synthetic origin,integrated with different therapeutic approaches for the treatment of diversetumors.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Springer  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Cancer  
dc.subject
NANOPARTICLES  
dc.subject
NATURAL COMPOUNDS  
dc.subject
SYNTHETIC DRUGS  
dc.subject
TREATMENT  
dc.subject.classification
Otras Ciencias de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Synthetic and Natural Drug Nanodelivery Systems Used in Oncology Treatment  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/bookPart  
dc.type
info:ar-repo/semantics/parte de libro  
dc.date.updated
2025-05-23T12:20:30Z  
dc.journal.pagination
1-33  
dc.journal.pais
Suiza  
dc.description.fil
Fil: Mirakian, Nadia Talín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; Argentina  
dc.description.fil
Fil: Papademetrio, Daniela Laura. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Inmunología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Sülsen, Valeria Patricia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; Argentina  
dc.description.fil
Fil: Carlucci, Adriana Mónica. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://doi.org/10.1007/16833_2024_403  
dc.conicet.paginas
426  
dc.source.titulo
Interdisciplinary Cancer Research